Marina Shcherba is an Oncologist in Middletown, New Jersey. Dr. Shcherba is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Familial Pancreatic Cancer.

An expert in cancer care, Dr. Ellen Early brings broad-based knowledge and expertise to Atlantic Medical Group. She joins Atlantic Hematology Oncology, a growing team that is housed at Carol G. Simon Cancer Center at Morristown Medical Center. Board certified in internal medicine and medical oncology, Dr. Early diagnoses and treats cancer patients using a multidisciplinary approach, which includes radiation and surgical oncology and incorporates clinicians who work collaboratively to deliver the highest quality cancer care possible. In practice for over 25 years, Dr. Early has particular interest in caring for people with breast and lung cancers. Regarded by patients, families and colleagues for both her expertise and her compassion, Dr. Early strives to educate patients about their condition and discuss how to choose the best individualized treatment plan. Passionate about research, Dr. Early has participated in clinical trials throughout her professional career and utilizes chemotherapies, medications and targeted modalities to treat cancers of the breast and lung. After graduating from Saint Peter's University with a bachelor's of science in Biology, Dr. Early went on to achieve her master's degree in molecular biology at City University of New York in Brooklyn. She attended Georgetown University School of Medicine and performed both her internal medicine residency and her fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Dr. Early is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Dr. Kai Bickenbach provides cancer patients with exceptional surgical care at Atlantic Surgical Oncology. His areas of specialty include melanoma, sarcoma, pancreatic cancer, liver and biliary cancer, esophageal and gastric cancer and colorectal cancer. He is trained in the use of many novel therapies, including the NanoKnife® to treat un-resectable pancreatic and liver tumors, as well as hepatic arterial infusion pumps. Dr. Bickenbach and his partners are fellowship trained surgical oncologists providing patients the latest in surgical innovation and clinical research options. Atlantic Surgical Oncology Associates work closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and Overlook Medical Center in Summit. Dr. Bickenbach is a member of a variety of medical organizations including the American College of Surgeons, the Society of Surgical Oncology, the American Society of Clinical Oncology, and the Americas Hepato-Pancreatico-Biliary Association, and is a councilman for the New Jersey Chapter of the American College of Surgeons. He is widely published and has presented at national meetings on cancer related topics.After graduating from Wayne State University School of Medicine in 2002, Dr. Bickenbach completed his surgical residency at the University of Chicago Medical Center in 2009, where he was elected administrative chief resident. During that time, Dr. Bickenbach completed a two-year research fellowship, focusing on the use of oncolytic viruses in the treatment of cancer. Following residency, Dr. Bickenbach completed a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center. He sees patients at Morristown, Overlook, Newton, Chilton and Hackettstown medical centers. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Bickenbach is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy.

Lawrence Harrison, MD, is chief of Atlantic Surgical Oncology, which provides expert care across a broad spectrum of cancers, focusing on hepatobiliary, pancreatic, colorectal, gastroesophageal, skin and soft tissue cancers. As fellowship-trained surgical oncologists, Dr. Harrison and his partners provide patients with the latest in surgical innovations and clinical research options. Atlantic Surgical Oncology works closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and at Overlook Medical Center in Summit. Dr. Harrison has been a surgical innovator since finishing fellowship training at Memorial Sloan Kettering Cancer Center in New York City. He has extensive training in novel surgical techniques, including in hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery. Prior to joining Atlantic Surgical Oncology, Dr. Harrison served as director of surgical oncology at Valley Hospital in Ridgewood where he developed expertise in robotic surgery, performing more than 200 complex robotic surgical procedures. He also was director of the Advanced Gastrointestinal Surgical Fellowship. Previously, Dr. Harrison was associate professor of surgery and chief of the Division of Surgical Oncology at University Hospital in Newark for 12 years. In addition to his clinical practice, he was involved in research and taught medical residents and students. He is a fellow of the American College of Surgeons. Dr. Harrison sees patients at Morristown and Overlook medicals centers, and provides consultative services to Newton, Chilton and Hackettstown medical centers. Dr. Harrison is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer.

Jason Maggi is a Surgical Oncologist and a General Surgeon in Jersey City, New Jersey. Dr. Maggi is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Gastrointestinal Perforation, Colorectal Cancer, Familial Colorectal Cancer, Colostomy, and Hernia Surgery.

Martin Gutierrez is a Medical Genetics provider in Hackensack, New Jersey. Dr. Gutierrez is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Colorectal Cancer, and Tissue Biopsy.

Tracy Proverbs is an Oncologist in Hackensack, New Jersey. Dr. Proverbs is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, Endoscopy, and Gastrostomy.

Stephen Zrada is a Hematologist and an Oncologist in Sewell, New Jersey. Dr. Zrada is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Paget Disease of the Breast. Dr. Zrada is currently accepting new patients.

Levi Sokol is a Radiologist in East Brunswick, New Jersey. Dr. Sokol is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Pleurisy, Pleural Effusion, Classical Hodgkin Lymphoma, and Lung Nodules.

Gamil Hanna is an Oncologist in Cherry Hill, New Jersey. Dr. Hanna is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Familial Prostate Cancer, Small Lymphocytic Lymphoma (SLL), Childhood Iron Deficiency Anemia, and Urothelial Cancer. Dr. Hanna is currently accepting new patients.

Jason Levitz is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Levitz is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Polycythemia Vera, Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Levitz is currently accepting new patients.

Lee Starker, MD, PhD, is a medical director of surgical oncology for the eastern region with a special interest in thyroid and parathyroid tumors and cancers, endocrine disorders, melanoma, hormones and metabolism, and cancer genetics. He is highly trained in pancreatic and complex hepatobiliary surgery. He also specializes in NanoKnife® to treat unresectable pancreatic and liver cancers as well as hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery for peritoneal malignancies.After completing his surgical residency at Yale New Haven Hospital in Connecticut and surgical oncology fellowship training at MD Anderson Cancer Center in Texas, Dr. Starker returned to his New Jersey roots. Prior to that, he earned a PhD in epigenetics and genetics of parathyroid tumors from Uppsala University in Sweden, where he was chief resident and fellow. While studying there, he received the Gold Humanism Award, which recognizes excellence in clinical care, leadership, compassion and dedication to service. He has also been named an NJ Top Doctor annually by NJ Monthly Magazine.Dr. Starker is widely published in various medical journals, including the World Journal of Oncology and International Journal of Endocrinology. He is a member of the Society of Surgical Oncology. Dr. Starker and his partners provide patients with the latest surgical innovations and clinical research options. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Starker is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.

Amit Kharod is a General Surgeon in Freehold, New Jersey. Dr. Kharod is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Choledocholithiasis, Cholecystitis, Hernia, Hernia Surgery, and Gastrostomy. Dr. Kharod is currently accepting new patients.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

James R. Wong, MD, is a radiation oncologist and founder and medical director of the Leonard B. Kahn Head and Neck Cancer Institute at Morristown Medical Center. He specializes in treating head and neck cancers, nasopharyngeal cancer, breast cancer, gastrointestinal cancer, brain tumors and prostate cancer. In 1997, Dr. Wong was named chair of Radiation Oncology at Morristown Medical Center where he presided over the reorganization and development of the new Department of Radiation Oncology. A year later, he was appointed associate clinical professor of radiation oncology at Columbia University, College of Physicians and Surgeons. In 2004, he was appointed by New Jersey Governor Jim McGreevey to the task force on the Prevention, Detection and Treatment of Cancer.Recently, Dr. Wong has developed an interest in incorporating Integrative Medicine and complementary supportive care in the treatment and recovery plans for his patients. Dr. Wong has launched “Integrate to Wellness,” a ten-week program using therapies such as acupuncture and stress management. Before arriving at Atlantic Health System, Dr. Wong served as assistant professor of radiology at the New York Hospital, Cornell University Medical College. He was also the director of radiation oncology fellows and the director of radiation oncology research at the New York Hospital/Cornell Medical Center. At the Stich Radiation Center of New York Hospital, he was in charge of radiation therapy for brain tumors and stereotactic radiosurgery.Graduating summa cum laude from Harvard College, Dr. Wong received his medical degree from Harvard Medical School where he became one of the few honor graduates of his year. He practiced internal medicine at the New England Deaconess Hospital, Harvard Medical School, and continued on for four more years of specialty training in radiation oncology at the Harvard Joint Center for Radiation Therapy. During his 15 years at Harvard, he published many articles in leading scientific journals, including Proceedings of the National Academy of Science, Cell, Journal of Biochemistry, and Cancer Research.Dr. Wong has been selected as one of the “Top Prostate Cancer Specialists” in the United States and is considered a pioneer of image-guided radiation therapy. He was elected by his peers for inclusion in “Best Doctors in America®” for five consecutive years. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Adenoid Cystic Carcinoma, Laryngeal Cancer, Thymic Epithelial Tumor, and Familial Prostate Cancer.

Jaimin Shah is a Radiologist and an Interventional Radiologist in Morristown, New Jersey. Dr. Shah has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Ascites, Familial Pancreatic Cancer, Lung Cancer, Liver Embolization, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

Maithili Rao, MD, is a senior health care entrepreneur board-certified in medical oncology and hematology by the American Board of Internal Medicine. She is affiliated with Advanced Care Oncology and Hematology Associates (ACOHA), part of Atlantic Medical Group (AMG). Her professional career includes building a worldclass oncology practice across six counties with 30 practitioners, serving as a medical executive board member at Overlook Hospital, and working as the enterprise medical director of Practice Growth and Integration at Atlantic Medical Group. Dr. Rao has championed an integrated approach to treating cancer and blood disorders, focusing on personalizing patient care, quality, and communication.At each oncology treatment site, Dr. Rao has successfully incorporated palliative care, genetic counseling, dietitians, navigators, social workers, onsite lab and pharmacy services, access to clinical trials, an infusion suite for chemotherapy and immunotherapy, and advanced molecular testing. These integrations enable her to deliver high-quality clinical care and innovative treatment protocols with a unique, holistic, patient-centered approach. She treats all forms of blood disease and cancer, with a special focus on breast cancer.Dr. Rao currently serves as the enterprise medical director of oncology and other specialties for Atlantic Health System (AHS), a multi-award-winning, seven-hospital, nonprofit, integrated health care network in northern New Jersey. AHS has over 400 sites of care, 300 physician practices, and 17,000 team members. Dr. Rao provides clinical and strategic direction for cancer care and has successfully transformed cancer care in New Jersey from a community-focused initiative to a leading oncology center that rivals prestigious competitors in New York City.Dr. Rao has been recognized by the American Cancer Society as a Medical Honoree and has been voted by her peers as New Jersey Monthly’s Top Doctor for over 13 years, among other accolades. Dr. Rao is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Thrombocytopenia, and Bone Marrow Aspiration.

Joseph Pepek is a Radiation Oncologist in Freehold Township, New Jersey. Dr. Pepek is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, Intraductal Papilloma, and Pancreaticoduodenectomy. Dr. Pepek is currently accepting new patients.

Trina Poretta is an Oncologist in Voorhees, New Jersey. Dr. Poretta is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Breast Cancer, and Paget Disease of the Breast.